last updated: 2024-02-29
Goals:
- Towards a tool to build collective intelligence - Mechanism to share
best practices, and evolve. - Code sharing - Color scheme options -
Extra support on select languages
Epidemiological MODeling software (EMOD) (agent-based model for multiple diseases)
Author: Kurt Frey
ggplot(somedata, aes(x= x, y=y, linetype=case)) +
geom_line() +
facet_wrap(~region) +
theme_bw()
source: (Frey, K. 2022)
Author: Kurt Frey
ggplot(somedata, aes(x= years, y=rural_fraction, color=case)) +
geom_point()
geom_point(mean_data, aes(x= years, y=rural_fraction, color=case), size=4) +
scale_x_conintous(breaks=seq(0.1, 0.6, y=0.1), '<15yrs Fraction') +
theme_idm()
source: (Frey, K. 2022)
Author: Kurt Frey
ggplot(somedata, aes(x= years, y=rural_fraction, color=case)) +
geom_point()
geom_point(mean_data, aes(x= years, y=rural_fraction, color=case), size=4) +
scale_x_conintous(breaks=seq(0.1, 0.6, y=0.1), '<15yrs Fraction') +
facet_wrap(~region) +
theme_idm()
source: (Frey, K. 2022)
Author: M Zimmerman
p.region1 <- ggplot(somedata, aes(x= years, y=rural_fraction, color=case)) +
geom_point()
geom_point(mean_data, aes(x= years, y=rural_fraction, color=case), size=4) +
scale_x_conintous(breaks=seq(0.1, 0.6, y=0.1), '<15yrs Fraction') +
facet_wrap(~region) +
theme_idm()
ggarange()
#
#source: (Zimmermann 2019)
source: (Zimmermann 2019)
ggplot(somedata, aes(x= years, y=rural_fraction, color=case)) +
geom_point()
geom_point(mean_data, aes(x= years, y=rural_fraction, color=case), size=4) +
scale_x_conintous(breaks=seq(0.1, 0.6, y=0.1), '<15yrs Fraction') +
theme_idm()
source: (O’Brien 2023)
ggplot(Mean_Total,aes(x=Year,y=MeanHrs/WeeksPerYr,group=Scenario_ID,color=Scenario_ID))+
geom_line()+
theme_bw()+
facet_wrap(~adminName,scales="free_y")
ggplot(Mean_Total,aes(x=Year,y=MeanHrs/WeeksPerYr,group=adminName,linetype=adminName))+
geom_line()+
theme_bw()+
facet_wrap(~Scenario_ID,scales="free_y")
source: (Hagendorn 2023)
link to full R-script in databricks: link here in databricks
ggplot(Mean_Total,aes(x=Year,y=MeanHrs/WeeksPerYr,group=Scenario_ID,color=Scenario_ID))+
geom_line()+
theme_bw()+
facet_wrap(~adminName,scales="free_y")
ggplot(Mean_Total,aes(x=Year,y=MeanHrs/WeeksPerYr,group=Scenario_ID,color=Scenario_ID))+
geom_line()+
theme_bw()+
facet_wrap(~adminName,scales="free_y")
source: (Mercer 2023)
Frey, K., et al. (2022). Modeling anticipated changes in numbers of SARS-CoV-2 infections within communities due to immunization campaigns. Gates Open Research, 6.
Hagedorn, B., Han, R., Eliot, C., Wu, M., Schripsema, J., & McCarthy, K. (2023). Implementation and applications of PACE-HRH, a stochastic workload model of human resources for health.
Hagedorn, B. L., Han, R., & McCarthy, K. A. (2023). One size does not fit all: an application of stochastic modeling to estimating primary healthcare needs in Ethiopia at the sub-national level. BMC Health Services Research, 23(1), 1070.
Mercer, L. D., Lu, F., & Proctor, J. L. (2019). Sub-national levels and trends in contraceptive prevalence, unmet need, and demand for family planning in Nigeria with survey uncertainty. BMC Public Health, 19(1), 1-9.
Noori, N., Skrip, L. A., Oron, A. P., McCarthy, K. A., Proctor, J. L., Chabot-Couture, G., … & Trehan, I. (2022). Potential Impacts of Mass Nutritional Supplementation on Measles Dynamics: A Simulation Study. The American Journal of Tropical Medicine and Hygiene, 107(4), 863.
O’Brien, M. L., Valente, A., Kerr, C. C., Proctor, J. L., Noori, N., Root, E. D., … & Zimmermann, M. (2023). FPsim: An agent-based model of family planning. npj Women’s Health, 1(1), 1.
Ribado, J. V., Li, N. J., Thiele, E., Lyons, H., Cotton, J. A., Weiss, A., … & Proctor, J. L. (2021). Linked surveillance and genetic data uncovers programmatically relevant geographic scale of Guinea worm transmission in Chad. PLOS Neglected Tropical Diseases, 15(7), e0009609.
Zimmermann, M., Frey, K., Hagedorn, B., Oteri, A. J., Yahya, A., Hamisu, M., … & Chabot-Couture, G. (2019). Optimization of frequency and targeting of measles supplemental immunization activities in Nigeria: a cost-effectiveness analysis. Vaccine, 37(41), 6039-6047.